Management of diabetic nephropathy: the role of sirtuin-1

Future Medicinal ChemistryVol. 11, No. 17 CommentaryManagement of diabetic nephropathy: the role of sirtuin-1Wanning Wang, Weixia Sun, Yanli Cheng, Zhonggao Xu & Lu CaiWanning WangDepartment of Nephrology, the First Hospital of Jilin University, Changchun 130021, ChinaPediatric Research Institute, Department of Pediatrics, the University of Louisville School of Medicine, Louisville, KY 40292, USASearch for more papers by this author, Weixia SunDepartment of Nephrology, the First Hospital of Jilin University, Changchun 130021, ChinaSearch for more papers by this author, Yanli Cheng*Author for correspondence: Tel.: +86 159 4305 3309; Fax: +86 431 8565 4528; E-mail Address: leoai918@163.comDepartment of Nephrology, the First Hospital of Jilin University, Changchun 130021, ChinaSearch for more papers by this author, Zhonggao XuDepartment of Nephrology, the First Hospital of Jilin University, Changchun 130021, ChinaSearch for more papers by this author & Lu CaiPediatric Research Institute, Department of Pediatrics, the University of Louisville School of Medicine, Louisville, KY 40292, USADepartments of Radiation Oncology, Pharmacology & Toxicology, the University of Louisville School of Medicine, Louisville, KY 40292, USASearch for more papers by this authorPublished Online:4 Oct 2019https://doi.org/10.4155/fmc-2019-0153AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleReferences1. Hong Q, Zhang L, Das B et al. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. Kidney Int. 93(6), 1330–1343 (2018).Crossref, Medline, CAS, Google Scholar2. Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of SIR1 in diabetic Wistar fatty (fa/fa) rats: a model of Type 2 diabetes. Exp. Diabetes Res. 2011, 1–11 (2011).Crossref, Google Scholar3. Mansur AP, Roggerio A, Goes MFS et al. Serum concentrations and gene expression of sirtuin 1 in healthy and slightly overweight subjects after caloric restriction or resveratrol supplementation: a randomized trial. Int. J. Cardiol. 227, 788–794 (2017).Crossref, Medline, Google Scholar4. Liu HW, Kao HH, Wu CH. Exercise training upregulates SIRT1 to attenuate inflammation and metabolic dysfunction in kidney and liver of diabetic db/db mice. Nutr. Metab. (Lond.) 16, 22 (2019).Crossref, Medline, Google Scholar5. Tang LX, Wang B, Wu ZK. Aerobic exercise training alleviates renal injury by interfering with mitochondrial function in Type-1 diabetic mice. Med. Sci. Monit. 24, 9081–9089 (2018).Crossref, Medline, CAS, Google Scholar6. Rogacka D, Audzeyenka I, Rychlowski M et al. Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK. Biochim. Biophys. Acta 1864(1), 115–125 (2018).Crossref, CAS, Google Scholar7. Zhai L, Gu J, Yang D, Hu W, Wang W, Ye S. Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in Type 2 diabetic rats. J. Diabetes 9(5), 510–517 (2017).Crossref, Medline, CAS, Google Scholar8. Wang C, Li L, Liu S et al. GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis. PLoS ONE 13(3), e0193473, 1–16 (2018).Crossref, Medline, Google Scholar9. Wanner C, Inzucchi SE, Lachin JM et al. Empagliflozin and progression of kidney disease in Type 2 diabetes. N. Engl. J. Med. 375(4), 323–334 (2016).Crossref, Medline, CAS, Google Scholar10. Kim H, Baek CH, Lee RB, Chang JW, Yang WS, Lee SK. Anti-fibrotic effect of losartan, an angiotensin II receptor blocker, is mediated through inhibition of ER stress via up-regulation of SIRT1, followed by induction of HO-1 and thioredoxin. Int. J. Mol. Sci. 18(2), pii:E305 (2017).Crossref, Google Scholar11. Gu J, Yang M, Qi N et al. Olmesartan prevents microalbuminuria in db/db diabetic mice through inhibition of angiotensin II/p38/SIRT1-induced podocyte apoptosis. Kidney Blood Press. Res. 41(6), 848–864 (2016).Crossref, Medline, CAS, Google Scholar12. Mendez-Del Villar M, Gonzalez-Ortiz M, Martinez-Abundis E, Perez-Rubio KG, Lizarraga-Valdez R. Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab. Syndr. Relat. Disord. 12(10), 497–501 (2014).Crossref, Medline, Google Scholar13. Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol reduces albuminuria in diabetic nephropathy: a randomized double-blind placebo-controlled clinical trial. Diabetes Metab. 45(1), 53–59 (2019).Crossref, Medline, CAS, Google Scholar14. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-associated renal toxicity. Toxicol. Sci. 82(2), 614–619 (2004).Crossref, Medline, CAS, Google Scholar15. Xu X, Zheng N, Chen Z, Huang W, Liang T, Kuang H. Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress. Gene 591(2), 411–416 (2016).Crossref, Medline, CAS, Google Scholar16. Wang B, Chen S, Yan X et al. The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy: a meta-analysis. Altern. Ther. Health Med. 21(1), 36–44 (2015).Medline, Google Scholar17. Oza MJ, Kulkarni YA. Formononetin attenuates kidney damage in Type 2 diabetic rats. Life Sci. 219, 109–121 (2019).Crossref, Medline, CAS, Google Scholar18. Wang X, Gao Y, Tian N et al. Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-kappaB p65 axis. Sci. Rep. 9(1), 323 (2019).Crossref, Medline, Google Scholar19. Milne JC, Lambert PD, Schenk S et al. Small molecule activators of SIRT1 as therapeutics for the treatment of Type 2 diabetes. Nature 450(7170), 712–716 (2007).Crossref, Medline, CAS, Google Scholar20. Pacholec M, Bleasdale JE, Chrunyk B et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285(11), 8340–8351 (2010).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByNEAT1: A Novel Long Non-coding RNA Involved in Mediating Type 2 Diabetes and its Various ComplicationsCurrent Pharmaceutical Design, Vol. 28, No. 16Rhein Improves Renal Fibrosis by Restoring Cpt1a-Mediated Fatty Acid Oxidation through SirT1/STAT3/twist1 Pathway6 April 2022 | Molecules, Vol. 27, No. 7MiR‐138 plays an important role in diabetic nephropathy through SIRT1–p38–TTP regulatory axis12 April 2021 | Journal of Cellular Physiology, Vol. 236, No. 9Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3Redox Biology, Vol. 38PARP-1 and SIRT-1 are Interacted in Diabetic Nephropathy by Activating AMPK/PGC-1α Signaling Pathway1 January 2021 | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. Volume 14 Vol. 11, No. 17 Follow us on social media for the latest updates Metrics Downloaded 144 times History Received 14 May 2019 Accepted 12 July 2019 Published online 4 October 2019 Published in print September 2019 Information© 2019 Newlands PressFinancial & competing interests disclosureAuthors’ work cited in this review was supported in part by grants from the National Natural Science Foundation of China (grant numbers 81400725 to [W Sun] and 81700635 to [Y Cheng]), Natural Science Foundation of Jilin Province (grant number 20160101030JC to [W Sun]), the 13th five-year scientific research planning program of Jilin province (grant number JJKH20180210KJ to [W Sun]), the National Postdoctoral Program for Innovative Talents (grant number BX201700098 to [Y Cheng] and the Postdoctoral Science Foundation of China (grant number 2017M621216 to [Y Cheng]). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.Writing assistance was utilized in the production of this manuscript.PDF download